Introduction
============

Worldwide, bacterial vaginosis (BV) is considered to be one of the most prevalent gynecological disorders of reproductive-age women and one of the most common causes of vaginal symptoms, prompting women to seek medical care ([@ref-35]). This vaginal infection is microbiologically characterized by the replacement of a *Lactobacillus*-dominated vaginal microbiota by variable mixtures of strictly and facultative anaerobic bacteria including *Gardnerella vaginalis, Atopobium vaginae* and *Mobiluncus* spp. ([@ref-37]).

Currently, the presence of BV during pregnancy has attracted the attention of both clinicians and the scientific community, due to its relation with adverse pregnancy consequences such as preterm delivery ([@ref-23]) and miscarriage ([@ref-24]). The mechanisms involved in pregnancy complications induced by BV are not fully clarified, but many researchers suggest that preterm delivery results from bacteria ascension from vagina to the membranes and amniotic fluid ([@ref-13]; [@ref-30]). In recent years, several studies demonstrated that the presence or high load of vaginal microbes associated to BV such as *G. vaginalis*, *A. vaginae*, *Mobiluncus* spp., *Mycoplasma* spp. and *Leptotrichia/Sneathia* species, were related with an increased risk of preterm birth ([@ref-10]; [@ref-27]; [@ref-4]; [@ref-22]). However, the great diversity of vaginal microbiota in women with BV affects its potential to develop preterm birth and other negative outcomes in pregnancy ([@ref-19]; [@ref-28]) and it becomes BV treatment in pregnant women a challenging task ([@ref-16]). Despite of its high impact, few epidemiological studies on BV have been conducted in Portugal ([@ref-15]; [@ref-34]; [@ref-25]). Specifically, there is no information related to the prevalence of BV among Portuguese pregnant women. As such, we set this first epidemiological study aimed to determine the prevalences of BV and of *G. vaginalis* vaginal colonization in Portuguese pregnant women.

Materials & Methods
===================

Population, data and biological samples collection
--------------------------------------------------

This cross-sectional study involved pregnant women attending prenatal care consultations in two public Portuguese hospitals of the Northwest region (Hospital of Braga and Unidade Local de Saúde de Matosinhos), between May 2014 and May 2016. The inclusion criteria for the present study were: to be pregnant at any gestational age and to be older than 18 years. The exclusion criteria were: women who were unable to read or understand Portuguese and who did not accept to participate in study.

During prenatal care consultation, obstetricians invited all eligible women under their care to participate in the study. All participants signed the informed consent form, as approved by the respective local ethical committees. Afterwards, the participants were questioned by the obstetricians about their age, educational level (basic, secondary or university), if they had previous BV episodes, previous deliveries, history of preterm delivery, suffered of chronic disease or smoking and about its use of intimate hygienic products and vitamin supplements, and determined the current gestational period (first, second or third trimester). A short standardized questionnaire was used to collect these data. Finally, the obstetricians collected vaginal samples (only one sample point was taken for each participant), using sterile swab containing Amies transport medium with coal (VWR, Radnor, PA, USA). After collection, the swabs were immediately conserved at 4 °C and transported to the Laboratory of Research in Biofilms Rosário Oliveira of the University of Minho, where they were processed.

Gram staining and BV diagnosis
------------------------------

For BV diagnosis, a direct smear was performed by transferring the vaginal fluid present on the swab to a glass slide. Then, vaginal smears were heat-fixed and Gram stained ([@ref-36]). Afterwards, the smears were visualized using an Olympus BX51 microscope (Olympus Portugal SA, Lisboa, Portugal) under oil immersion objective (1,000× magnification) and, subsequently, graded in accordance with the Nugent scoring system ([@ref-29]). In summary, on 10 microscopic fields, the following bacterial morphotypes were identified and quantified: large gram-positive rods (*Lactobacillus* spp.), small gram-variable rods (*G. vaginalis*), small gram-negative rods (*Bacteroides* spp.) and curved gram-variable rods (*Mobiluncus* spp.). The sum of each morphotype score allowed to classify vaginal flora into normal (score 0--3), intermediate (score 4--6) or BV (score 7--10).

Molecular detection of *G. vaginalis*
-------------------------------------

Each vaginal swab was then immersed in 2 mL of 0.9% (wt/v) of sodium chloride (Liofilchem; Roseto degli Abruzzi, Italy) and the content was suspended using vigorous vortexing. Afterwards, 1.5 mL of each diluted swab content was transferred into a tube that was centrifuged at 8,000 rpm, during 10 s, in order to allow for coal deposition at the bottom of the tube. Then, 0.6 mL of supernatant was collected to a new tube and this later was centrifuged at 13,500 rpm, during 5 min. At the end, the supernatant was discarded and the pellet was suspended in 0.1 mL of sterile ultra-pure water. This bacterial suspension was incubated in a heating block at 95 °C for 20 min in order to disrupt bacterial cell wall and release the cell content, making available the genomic DNA that is required for polymerase chain reaction (PCR). After incubation, it was immediately cooled on ice for 5 min and the cell suspension was centrifuged at 13,500 rpm, during 5 min. The supernatant was used as template for a multiplex PCR since we used the PCR to amplify different DNA sequences simultaneously (namely gene encoding 16S rRNA of *G. vaginalis* and *aap* gene of *Staphylococcus epidermidis*). Briefly, each PCR included 6 µL of Dream Taq PCR Master Mix 2X (Thermo Fisher Scientific, Waltham, MA, USA), 1 µL of DNA from the vaginal sample, 2 µL of distilled water DNase/RNAse free (Thermo Fisher Scientific), 0.5 µL of 5 µM forward (FW1) *G. vaginalis* primer , 0.5 µL of 5 µM reverse (RV1) *G. vaginalis* primer, 0.5 µL of 5 µM FW *S. epidermidis* primer, 0.5 µL of 5 µM RV *S. epidermidis* primer and 1 µL of complementary DNA of *S. epidermidis*. Also, a negative control (containing 1 µL of DNase/RNase free water instead of genomic DNA) and positive control (containing 1 µL of genomic DNA from pure culture of *G. vaginalis*) were included in each set of reactions. The tubes were placed in a thermocycler (Bio-Rad; Hercules, CA, USA) that was programmed with the following protocol: 94 °C for 2 min, 40 steps of 94 °C for 30 s, 60 °C for 30 s, 72 °C for 1 min and finally 72 °C for 5 min. The inclusion of the specific primers for the *S. epidermidis aap* gene acted as internal positive control of PCR procedure, in order to ensure that amplifiable DNA was successfully extracted and there are no PCR inhibitors on sample.

After the PCR reaction, amplified products were analyzed in 1% (wt/v) of agarose (SeaKem LE; Rockland, ME, USA) gel with 0.05 µL/mL midori green nucleic acid dye (Nippon Genetics Europe GmbH, Düren, Germany). The electrophoresis run for 50 min at 100 volts. Finally, the results were visualized using the ChemiDoc (Bio-Rad) system, according to the manufacturer's instructions. Negative results for the amplification of the gene encoding 16S rRNA of *G. vaginalis* were confirmed using an independent set of primers (FW2/RV2). All primers used are described in [Table 1](#table-1){ref-type="table"} and were previously assessed for specificity ([@ref-11]; [@ref-18]; [@ref-6]).
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###### Primers used in this study.

![](peerj-05-3750-g001)

  Target                  Set                     Sequence (5′--3′)      TM (° C)                                                                                  Amplification region (GenBank)                                                           Reference
  ----------------------- ----------------------- ---------------------- ----------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------- -----------
  *G. vaginalis* 16SRNA   FW1                     CTCTTGGAAACGGGTGGTAA   60                                                                                        [KP996686.1](https://www.ncbi.nlm.nih.gov/nucleotide?term=KP996686.1) (from 99 to 399)   [@ref-18]
  RV1                     TTGCTCCCAATCAAAAGCGGT   62                                                                                                                                                                                                        
  FW2                     AGCCTAGGTGGGCCATTACC    59                     [KP996686.1](https://www.ncbi.nlm.nih.gov/nucleotide?term=KP996686.1) (from 206 to 373)   [@ref-6]                                                                                 
  RV2                     TGAGTAATGCGTGACCAACC    55                                                                                                                                                                                                        
  *S. epidermidis* aap    FW                      GCACCAGCTGTTGTTGTACC   59                                                                                        [CP020463.1](http://www.ncbi.nlm.nih.gov/nuccore/CP020463.1) (from 11,0863 to 11,1053)   [@ref-11]
  RV                      GCATGCCTGCTGATAGTTCA    60                                                                                                                                                                                                        

**Notes.**

TMmelting temperatureFWforwardRVreverse

Statistical analysis
--------------------

Data were analyzed with GraphPad Prism version 6 (GraphPad Software Inc., La Jolla, CA, USA). Firstly, we determined BV and *G. vaginalis* colonization prevalences and then we used Chi-square or Fisher's exact test to verify whether BV positive status or *G. vaginalis* colonization were associated with some sociodemographic, medical, reproductive, behavioral or microbiological variables. A *p*-value \<0.05 was used as threshold for statistically significance. The strength of association between BV diagnosis or *G. vaginalis* colonization with the study variables was assessed through calculation of odds ratios (OR) and their 95% confidence intervals (CI).

Ethical considerations
----------------------

The study was approved by the ethics committees of Unidade Local de Saúde de Matosinhos (process 013/CE/JAS) and of Hospital of Braga (process SECVS 063/2014). All the study participants agreed through informed consent to collaborate voluntarily, anonymously and freely. To ensure confidentiality no personal data were recorded that could lead to identification of the participants.

Results
=======

Between May 2014 and May 2016, a total of 273 women followed in prenatal care consultation of two public Portuguese hospitals of the Northwest region agreed to participate in the current study. Among them, 67 had uninterpretable Gram-staining slides and where excluded from this study. [Table 2](#table-2){ref-type="table"} summarizes sociodemographic, medical, reproductive and behavioral characteristics of the studied population (*n* = 206). The participants had ages comprised between 19 and 41 years, resulting in mean age of 30.00 ± 5.16 years. Moreover, the majority of participants was in the third trimester of pregnancy (71.84%) and used vitamin supplementation (86.41%).
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###### Characteristics of the studied population (*n* = 206).

![](peerj-05-3750-g002)

  Variables                          (%)
  ---------------------------------- --------------
  Sociodemographic                   
  Age (mean ± SD, years)             30.00 ± 5.16
  \<30 years                         41.75
  ≥30 years                          58.25
  Educational level                  
  ≤Basic                             29.13
  Secondary                          35.44
  ≥University                        35.44
  Medical                            
  Previous BV                        7.77
  History of chronic disease         14.56
  Reproductive                       
  Previous delivery                  41.75
  Previous preterm delivery          6.80
  Pregnancy trimester                
  First                              11.65
  Second                             16.50
  Third                              71.84
  Behavioral                         
  Tobacco consumption                12.62
  Use of intimate hygiene products   28.64
  Vitamin supplementation            86.41

**Notes.**

SDstandard deviationBVbacterial vaginosis

Values are given as mean ± SD or percentage (%).

Among the 206 pregnant women, BV was diagnosed in only eight participants, resulting in a BV prevalence of 3.88% ([Table 3](#table-3){ref-type="table"}). Probably due to the low number of BV cases, we did not found any significant statistically association between BV and the risk factors considered in this study (*p*-value \> 0.05). Nevertheless, previous preterm delivery and colonization by *G. vaginalis* were factors with very high OR, that could be considered statistically significant for a 90% CI.
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###### Characterization of women with or without BV.

Sociodemographic, medical, reproductive, behavioral and microbiological variables among women with or without BV.

![](peerj-05-3750-g003)

  Variables                          BV positive (*n* = 8)   BV negative (*n* = 198)   *p* value   OR     95% CI
  ---------------------------------- ----------------------- ------------------------- ----------- ------ --------------
  Sociodemographic                                                                                        
  Age (mean ± SD, years)             32.00 ± 3.16            29.91 ± 5.21              0.14               
  \<30 years                         1                       85                                    0.19   0.02--1.57
  ≥30 years                          7                       113                                   5.27   0.64--43.63
  Educational level                                                                    0.97               
  ≤Basic                             2                       58                                    0.81   0.16--4.11
  Secondary                          3                       70                                    1.10   0.26--4.73
  ≥University                        3                       70                                    1.10   0.26--4.73
  Medical                                                                                                 
  Previous BV                        2                       14                        0.12        4.38   0.81--23.75
  History of chronic disease         3                       27                        0.09        3.80   0.86--16.83
  Reproductive                                                                                            
  Previous delivery                  4                       82                        0.72        1.42   0.34--5.82
  Previous preterm delivery          2                       12                        0.09        5.17   0.94--28.39
  Pregnancy trimester                                                                  0.27               
  First                              2                       22                                    2.67   0.51--14.04
  Second                             0                       34                                    0.28   0.02--4.98
  Third                              6                       142                                   1.18   0.23--6.04
  Behavioral                                                                                              
  Tobacco consumption                0                       26                        0.60        0.38   0.02--6.84
  Use of intimate hygiene products   4                       55                        0.23        2.60   0.63--10.76
  Vitamin supplementation            7                       171                       1.00        1.11   0.13--9.35
  Microbiological                                                                                         
  *G. vaginalis* presence            8                       131                       0.06        8.73   0.50--153.60

**Notes.**

BVbacterial vaginosisORodds ratioCIconfidence intervalSDstandard deviation

Values are given as mean ± SD or number.

Vaginal colonization by *G. vaginalis* was detected in 139 samples, representing a prevalence rate of 67.48% ([Table 4](#table-4){ref-type="table"}). Statistically significant differences between *G. vaginalis* positive and negative groups were found in relation to maternal educational level, current pregnancy trimester and vaginal microflora profile (*p* value \< 0.05). Of note is that basic educational level (OR = 2.77, 95% CI \[1.33--5.78\]), second pregnancy trimester (OR = 6.12, 95% CI \[1.80--20.85\]) and presence of BV flora (OR = 8.73, 95% CI \[0.50--153.60\]) were associated with higher rates of *G. vaginalis* colonization in these pregnant women.
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###### Characterization of women with or without vaginal colonization by *G. vaginalis*.

Sociodemographic, medical, reproductive, behavioral and microbiological variables among women with or without *G. vaginalis* colonization.

![](peerj-05-3750-g004)

  Variables                          GV positive (*n* = 139)   GV negative (*n* = 67)   *p* value   OR     95% CI
  ---------------------------------- ------------------------- ------------------------ ----------- ------ --------------
  Sociodemographic                                                                                         
  Age (mean ± SD, years)             29.94 ± 5.35              30.12 ± 4.78             0.88               
  \<30 years                         59                        27                                   1.09   0.60--1.98
  ≥30 years                          80                        40                                   0.92   0.51--1.66
  Educational level                                                                     0.02               
  ≤Basic                             49                        11                                   2.77   1.33--5.78
  Secondary                          47                        26                                   0.81   0.44--1.47
  ≥University                        43                        30                                   0.55   0.30--1.01
  Medical                                                                                                  
  Previous BV                        13                        3                        0.28        2.20   0.61--8.01
  History of chronic disease         24                        6                        0.14        2.12   0.82--5.47
  Reproductive                                                                                             
  Previous delivery                  62                        24                       0.29        1.44   0.79--2.63
  Previous preterm delivery          9                         5                        0.77        0.86   0.28--2.67
  Pregnancy trimester                                                                   \<0.01             
  First                              17                        7                                    1.19   0.47--3.04
  Second                             31                        3                                    6.12   1.80--20.85
  Third                              91                        57                                   0.33   0.16--0.71
  Behavioral                                                                                               
  Tobacco consumption                22                        4                        0.07        2.96   0.98--8.98
  Use of intimate hygiene products   45                        14                       0.10        1.81   0.91--3.61
  Vitamin supplementation            124                       54                       0.13        1.99   0.89--4.47
  Microbiological                                                                       0.02               
  Normal flora                       94                        56                                   0.41   0.20--0.86
  Intermediate flora                 37                        11                                   1.85   0.87--3.90
  BV flora                           8                         0                                    8.73   0.50--153.60

**Notes.**

GV*Gardnerella* vaginalisORodds ratioCIconfidence intervalSDstandard deviationBVbacterial vaginosis

Values are given as mean ± SD or number.

Discussion
==========

This is the first epidemiological study conducted in Portugal with the aim to assess the prevalence of BV among pregnant women, as well as to identify risk factors for BV and *G. vaginalis* colonization during pregnancy. In contrast with the high frequency of *G. vaginalis*, BV was diagnosed in only 3.88% of studied population. This BV prevalence rate is much lower than that reported by other Portuguese studies ([@ref-15]; [@ref-25]). Indeed, [@ref-15] detected a BV prevalence of 7% among 840 contraceptive users living in Lisbon region while [@ref-25] found a BV rate of 17.33%, among 150 young Portuguese women. Despite the lower cases of pregnant women with BV reported in this study, our results were consistent with other European studies. [@ref-9] described a BV prevalence rate of 4.9% in 1,441 Italian pregnant women while Gratacós and co-workers [@ref-14] found BV in 4.5% among 492 Spanish women with low risk pregnancies. Akinbiyi and colleagues [@ref-2] conducted a randomized prospective study to determine the prevalence and age distribution of *Candida albicans* and BV among English pregnant women, and found a BV prevalence of 3.54% (38/1073) with the majority of BV cases belonging to the age group of 21--30 years.

Contrasting with the very low prevalence of BV, in our study population, we found a *G. vaginalis* colonization rate of 67.48%. A significant higher colonization by *G. vaginalis* not associated to BV has been reported elsewhere ([@ref-8]; [@ref-20]). However, other epidemiological studies reported *G. vaginalis* colonization rates much lower than ours ([@ref-31]; [@ref-33]; [@ref-34]). These differences might be the result of significant different populations at study. In fact, recent genomic studies described that vaginal microbiome in pregnancy is unique and distinct of the non-pregnant women ([@ref-1]; [@ref-21]).

The observation that *G. vaginalis* colonization is not sufficient to cause BV, is not new ([@ref-3]; [@ref-12]; [@ref-26]). However, recent genomic studies have highlighted that *G. vaginalis* found in healthy women have distinct genetic profiles than isolates from women with BV ([@ref-32]; [@ref-20]). Interestingly, it has been proposed that some of the known *G. vaginalis* genotypes are, in fact, distinct species ([@ref-7]). This is supported by full genome sequence analysis and microbiology functional studies ([@ref-17]; [@ref-38]; [@ref-5]).

Conclusions
===========

For the first time, BV and *G. vaginalis* prevalence among Portuguese pregnant women were determined. We found that BV prevalence was low but *G. vaginalis* colonization was very high. Importantly, due to the small sample size, associations between BV and potential risk factors should be made with caution and as such, further studies involving a large number of participants and in different regions of the country should be performed in the future, to confirm our observations.
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